Kewaunee Scientific Corpo...

38.16
-1.99 (-4.96%)
At close: Mar 31, 2025, 11:23 AM

Kewaunee Scientific Statistics

Share Statistics

Kewaunee Scientific has 2.85M shares outstanding. The number of shares has increased by -0.11% in one year.

Shares Outstanding 2.85M
Shares Change (YoY) -0.11%
Shares Change (QoQ) 0%
Owned by Institutions (%) 42.94%
Shares Floating 2.1M
Failed to Deliver (FTD) Shares 178
FTD / Avg. Volume 0.64%

Short Selling Information

The latest short interest is 32.12K, so 1.12% of the outstanding shares have been sold short.

Short Interest 32.12K
Short % of Shares Out 1.12%
Short % of Float 1.54%
Short Ratio (days to cover) 2.16

Valuation Ratios

The PE ratio is 5.48 and the forward PE ratio is 28.49. Kewaunee Scientific's PEG ratio is 0.

PE Ratio 5.48
Forward PE 28.49
PS Ratio 0.5
Forward PS 0.7
PB Ratio 1.88
P/FCF Ratio 6.77
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Kewaunee Scientific Corporation has an Enterprise Value (EV) of 48.91M.

EV / Earnings 2.61
EV / Sales 0.24
EV / EBITDA 2.71
EV / EBIT 2.68
EV / FCF 3.22

Financial Position

The company has a current ratio of 2.37, with a Debt / Equity ratio of 0.2.

Current Ratio 2.37
Quick Ratio 1.87
Debt / Equity 0.2
Total Debt / Capitalization 16.73
Cash Flow / Debt 1.78
Interest Coverage 10.16

Financial Efficiency

Return on equity (ROE) is 0.34% and return on capital (ROIC) is 39.51%.

Return on Equity (ROE) 0.34%
Return on Assets (ROA) 0.14%
Return on Capital (ROIC) 39.51%
Revenue Per Employee $202,539.76
Profits Per Employee $18,641.15
Employee Count 1,006
Asset Turnover 1.51
Inventory Turnover 7.34

Taxes

Income Tax -5.94M
Effective Tax Rate -0.45

Stock Price Statistics

The stock price has increased by 15.29% in the last 52 weeks. The beta is 0.71, so Kewaunee Scientific's price volatility has been higher than the market average.

Beta 0.71
52-Week Price Change 15.29%
50-Day Moving Average 55.66
200-Day Moving Average 47.19
Relative Strength Index (RSI) 31.88
Average Volume (20 Days) 28K

Income Statement

In the last 12 months, Kewaunee Scientific had revenue of 203.75M and earned 18.75M in profits. Earnings per share was 6.51.

Revenue 203.75M
Gross Profit 52.05M
Operating Income 18.28M
Net Income 18.75M
EBITDA 18.04M
EBIT 18.28M
Earnings Per Share (EPS) 6.51
Full Income Statement

Balance Sheet

The company has 23.27M in cash and 11M in debt, giving a net cash position of 12.27M.

Cash & Cash Equivalents 23.27M
Total Debt 11M
Net Cash 12.27M
Retained Earnings 47.51M
Total Assets 189.15M
Working Capital 58.44M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 19.56M and capital expenditures -4.37M, giving a free cash flow of 15.19M.

Operating Cash Flow 19.56M
Capital Expenditures -4.37M
Free Cash Flow 15.19M
FCF Per Share 5.28
Full Cash Flow Statement

Margins

Gross margin is 25.55%, with operating and profit margins of 8.97% and 9.2%.

Gross Margin 25.55%
Operating Margin 8.97%
Pretax Margin 6.44%
Profit Margin 9.2%
EBITDA Margin 8.86%
EBIT Margin 8.97%
FCF Margin 7.46%

Dividends & Yields

KEQU pays an annual dividend of $0.95, which amounts to a dividend yield of 4.89%.

Dividend Per Share $0.95
Dividend Yield 4.89%
Dividend Growth (YoY) 11.76%
Payout Ratio 15.06%
Earnings Yield 16.41%
FCF Yield 13.42%
Dividend Details

Analyst Forecast

Currently there are no analyst rating for KEQU.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Jan 7, 1985. It was a forward split with a ratio of 3:2.

Last Split Date Jan 7, 1985
Split Type forward
Split Ratio 3:2

Scores

Altman Z-Score 2.7
Piotroski F-Score 5